Catalyst Wire Dossier Catalyst Wire Dossier

1% atropine '5+3' regimen

atropine 1%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 1% atropine '5+3' regimen, covering 2022-07-12 to 2022-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of 1% Atropine "5+3" Regimen in Children and Adolescents Controlling Myopia [Phase 4]

See pricing